Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | AMPD2 | Q01433 | 2/20 | 0.39 |
| ▸ | DRD4 | P21917 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | GRM6 | O15303 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9300647 | 0.86 | SIGMAR1 (0.43) | GAAKMT2AKDM4ESIGMAR1MTNR1A | |
| SCHEMBL28507735 | 0.85 | GAA (0.44) | GAAKMT2AALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL11477683 | 0.82 | EZH2 (0.53) | GAAKMT2ASMN1; SMN2KDM4EDRD4 | |
| SCHEMBL11656694 | 0.80 | AMPD2 (0.39) | GAAKMT2AALDH1A1KDM4EAMPD2 | |
| SCHEMBL9456562 | 0.80 | KMT2A (0.60) | KMT2AALDH1A1SMN1; SMN2DRD4SIGMAR1 | |
| SCHEMBL11158681 | 0.80 | TEAD1 (0.46) | GAAKMT2AALDH1A1KDM4EDRD4 | |
| SCHEMBL11479436 | 0.79 | DRD4 (0.47) | GAAKMT2ASMN1; SMN2KDM4EDRD4 | |
| SCHEMBL11369331 | 0.79 | ABL1 (0.42) | GAAKMT2AALDH1A1KDM4EDRD4 | |
| SCHEMBL9002978 | 0.78 | EZH2 (0.40) | GAAKMT2ASMN1; SMN2KDM4EEPHX1 | |
| SCHEMBL11136955 | 0.76 | CXCR3 (0.41) | GAAKMT2AAMPD2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9238609-B2 | Dicarboxylic acid monomers and methods of making and using the same | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2016-01-19 | — | — | US | disclosed |
| US-20150336869-A1 | DICARBOXYLIC ACID MONOMERS AND METHODS OF MAKING AND USING THE SAME | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-11-26 | — | — | US | disclosed |
| WO-2015171709-A1 | AMORPHOUS POLYESTER COMPOSITIONS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-11-12 | — | — | WO | disclosed |
| US-20150322200-A1 | AMORPHOUS POLYESTER COMPOSITIONS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-11-12 | — | — | US | disclosed |
| US-8633265-B2 | UV stabilization of isosorbide polycarbonates | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2014-01-21 | — | — | US | disclosed |
| EP-2665775-A1 | UV STABILIZATION OF ISOSORBIDE POLYCARBONATES | SABIC Innovative Plastics IP B.V. (NL) | 2013-11-27 | — | — | EP | disclosed |
| WO-2012098513-A1 | UV STABILIZATION OF ISOSORBIDE POLYCARBONATES | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2012-07-26 | — | — | WO | disclosed |
| US-20120184651-A1 | UV Stabilization of Isosorbide Polycarbonates | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2012-07-19 | — | — | US | disclosed |
| EP-0303279-B1 | Reactive hindered amine light stabilizers | ATOCHEM NORTH AMERICA ELF (US) | 1996-09-25 | — | — | EP | disclosed |
| EP-0410970-B1 | REACTIVE HINDERED AMINE LIGHT STABILIZERS | ATOCHEM NORTH AMERICA ELF (US) | 1996-08-14 | — | — | EP | disclosed |
| EP-0410970-A1 | REACTIVE HINDERED AMINE LIGHT STABILIZERS. | ATOCHEM NORTH AMERICA (US) | 1991-02-06 | — | — | EP | disclosed |
| US-4983738-A | For polymers | ATOCHEM NORTH AMERICA, INC. (US) | 1991-01-08 | — | — | US | disclosed |
| US-4978699-A | Reaction product of hindered amine with primary amine or reactive hydrazide group and halogenated cyclic anhydride; for extrusion with polymers | ATOCHEM NORTH AMERICA, INC. (US) | 1990-12-18 | — | — | US | disclosed |
| US-4975489-A | Heating an anhydride-containing polymer with a hydrazine derivative of a 2,2,6,6-tetramethyl-4-aminopiperidine in an inert solvent of by melt blending | ATOCHEM NORTH AMERICA, INC. (US) | 1990-12-04 | — | — | US | disclosed |
| EP-0366057-A2 | Light stabilizing flame retardants | ATOCHEM NORTH AMERICA, INC. (a Pennsylvania corp.) (US) | 1990-05-02 | — | — | EP | disclosed |
| US-4857595-A | Polymer bound hindered amine light stabilizers | PENNWALT CORPORATION (US) | 1989-08-15 | — | — | US | disclosed |
| US-4824884-A | Cyclic anhydride derivatives of hydrazide functionalized hindered amine light stabilizers | PENNWALT CORPORATION (US) | 1989-04-25 | — | — | US | disclosed |
| EP-0303987-A2 | Polymer bound hindered amine light stabilizers | ATOCHEM NORTH AMERICA, INC. (US) | 1989-02-22 | — | — | EP | disclosed |
| EP-0303279-A2 | Reactive hindered amine light stabilizers | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1989-02-15 | — | — | EP | disclosed |
| EP-0303282-A2 | Cyclic anhydride derivatives of hydrazide functionalized hindered amine light stabilizers | ATOCHEM NORTH AMERICA, INC. (US) | 1989-02-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150336869-A1 | DICARBOXYLIC ACID MONOMERS AND METHODS OF MAKING AND USING THE SAME | PGD, CDA, PPIA | GAA 995/4885KMT2A 1712/4885ALDH1A1 902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.